lenalidomide has been researched along with maytansine in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (maytansine) | Trials (maytansine) | Recent Studies (post-2010) (maytansine) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 815 | 96 | 592 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernöster, K; Häder, T; Pinkas, J; Schönfeld, K; Uherek, C; Zuber, C | 1 |
1 other study(ies) available for lenalidomide and maytansine
| Article | Year |
|---|---|
Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Evaluation, Preclinical; Humans; Immunoconjugates; Lenalidomide; Maytansine; Mice; Multiple Myeloma; Syndecan-1; Thalidomide | 2017 |